05.04.09
Alimera Sciences Announces Presentation Of Data From The 12-Month Interim Readout Of The Human PK ILUVIEN™ Study At ARVO 2009 Annual Meeting
Press Release
Applied Genetic stays inside to guard valuation
Dow Jones VentureWire
Arsenal Medical armed with $8M from insiders
05.01.09
Argos Therapeutics sees new promise for immunotherapeutics
TechJournal South
Applied Genetic Technologies adds $11.8M round to its DNA
04.24.09
Argos Therapeutics Presents Positive Transplantation and Immunosuppression Data for Soluble CD83 at the American Transplant Congress
04.20.09
Troy startup is a “Bright” spot in VC firm’s portfolio
The Business Review
04.13.09
Start-up Clarabridge takes the capital and scores
The Washington Post
04.08.09
Alimera Sciences’ Iluvien™ Phase 3 Studies For DME Pass Final DSMB Review Prior To October Readout
KAI Initiates Third Phase 2a Study to Develop KAI-1678 for the Treatment of Neuropathic Pain
